[
Ali FF, Rifaai RA. Preventive effect of omega-3 fatty acids in a rat model of stress-induced liver injury. J Cell Physiol 234, 11960–11968, 2019.10.1002/jcp.2784830536657
]Search in Google Scholar
[
Amini M, Bahmani F, Foroozanfard F, Vahedpoor Z, Ghaderi A, Taghizadeh M, Karbassizadeh H, Asemi Z. The effects of fish oil omega-3 fatty acid supplementation on mental health parameters and metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. J Psychosom Obstet Gynaecol 1–9, 2018.10.1080/0167482X.2018.150828230230402
]Search in Google Scholar
[
Arentz S, Smith CA, Abbott J, Bensoussan A. Nutritional supplements and herbal medicines for women with polycystic ovary syndrome; a systematic review and meta-analysis. BMC Complement Altern Med 17, 500, 2017.10.1186/s12906-017-2011-x570214129178904
]Search in Google Scholar
[
Avila MAP, Bruno RV, Barbosa FC, Andrade FC, Silva ACO, Nardi AE. Polycystic ovary syndrome: implications of metabolic dysfunction. Rev Col Bras Cirur 41, 106–110, 2014.10.1590/S0100-6991201400020000624918723
]Search in Google Scholar
[
Baptiste CG, Batistta MC, Trottier A, Baillargeon JP. Insulin and hyperandrogenism in women with polycystic ovary syndrome. J Steroid Biochem Mol Biol 122, 42–52, 2010.10.1016/j.jsbmb.2009.12.010384653620036327
]Search in Google Scholar
[
Barbalho SM, Bechara MD, Quesada KR, Goulart RA. Role of omega-3 fatty acids in the resolution of inflammatory processes. Medicina (Online) 44, 234–240, 2011.10.11606/issn.2176-7262.v44i3p234-240
]Search in Google Scholar
[
Becic T, Studenik C. Effects of omega-3 Supplementation on adipocytokines in prediabetes and type 2 diabetes mellitus: systematic review and meta-analysis of randomized controlled trials. Diabetes Metab J 42, 101–116, 2018.10.4093/dmj.2018.42.2.101591151329676540
]Search in Google Scholar
[
Buckley JD, Howe PRC. Long-chain omega-3 polyunsaturated fatty acids may be beneficial for reducing obesity – a review Nutrients 2, 1212–1230, 2010.10.3390/nu2121212325762622254005
]Search in Google Scholar
[
Cussons AJ, Watts GF, Mori TA, Stuckey BGA. Omega-3 fatty acid supplementation decreases liver fat content in polycystic ovary syndrome: a randomized controlled trial employing proton magnetic resonance spectroscopy. J Clin Endocrinol Metab 94, 3842–3848, 2009.10.1210/jc.2009-087019622617
]Search in Google Scholar
[
de Sousa RML, Chen MBC, da Silva DSM, Dutra MB, Navarro PAAS, Neto JAF, Brito LMO. Metabolic profile in women of different body mass indices with polycystic ovary syndrome. Rev Bras Ginecol Obstet 35, 413–420, 2013.10.1590/S0100-7203201300090000624217570
]Search in Google Scholar
[
Ebrahimi FA, Samimi M, Foroozanfard F, Jamilian M, Akbari H, Rahmani E Ahmadi S, Taghizadeh M, Memarzadeh MR, Asemi Z. The effects of Omega-3 fatty acids and vitamin E co-supplementation on indices of insulin resistance and hormonal parameters in patients with polycystic ovary syndrome: a randomized, double-blind, Placebo-Controlled Trial. Exp Clin Endocrinol Diab 125, 353–359, 2017.10.1055/s-0042-11777328407657
]Search in Google Scholar
[
Escobar-Morreale HF, Luque-Ramirez M, Gonzalez F. Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis. Fertil Steril 95, 048–1058, 2011.10.1016/j.fertnstert.2010.11.036307956521168133
]Search in Google Scholar
[
Foroozanfard F, Rafiei H, Samimi M, Gilasi HR, Gorjizadeh R, Heidar Z, Asemi Z. The effects of dietary approaches to stop hypertension diet on weight loss, anti-Müllerian hormone and metabolic profiles in women with polycystic ovary syndrome: A randomized clinical trial. Clin Endocrinol 87, 51–58, 2017.10.1111/cen.1333328316072
]Search in Google Scholar
[
Gonzalez F, Sia CL, Shepard MK, Rote NS, Minium J. Hyperglycemia-induced oxidative stress is independent of excess abdominal adiposity in normal-weight women with polycystic ovary syndrome. Human Repr 27, 3560–3568, 2013.10.1093/humrep/des320350124222940766
]Search in Google Scholar
[
Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol 7, 219–231, 2011.10.1038/nrendo.2010.21721263450
]Search in Google Scholar
[
Hajishafiee M, Askari G, Iranj B, Ghiasvand R, Bellissimo N, Totosy de Zepetnek J and Salehi-Abargouei A. The effect of n-3 polyunsaturated fatty acid supplementation on androgen status in patients with polycystic ovary syndrome: A systematic review and meta-analysis of clinical trials. Horm Met Res 48, 281–289, 2016.10.1055/s-0042-10528827077458
]Search in Google Scholar
[
Jamil AS, Alalaf SK, Al-Tawil NG, Al-Shawaf T. A case–control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria. Repr Health 12, 7, 2015.10.1186/1742-4755-12-7441724625595199
]Search in Google Scholar
[
Jamilian M, Shojaei A, Samimi M, Ebrahimi FA, Aghadavod E, Karamali M, Taghizadeh M, Jamilian H, Alaeinasab S, Jafarnejad S, Asemi Z. The effects of omega-3 and vitamin E co-supplementation on parameters of mental health and gene expression related to insulin and inflammation in subjects with polycystic ovary syndrome. J Affect Disord 229, 41–47, 2018.10.1016/j.jad.2017.12.04929306057
]Search in Google Scholar
[
Karakas SE, Perroud B, Kind T, Palazoglu M, Fiehn O. Changes in plasma metabolites and glucose homeostasis during omega-3 polyunsaturated fatty acid supplementation in women with polycystic ovary syndrome. BBA Clin 5, 179–185, 2016.10.1016/j.bbacli.2016.04.003485716027182493
]Search in Google Scholar
[
Khani B, Mardanian F, Fesharaki SJ. Omega-3 supplementation effects on polycystic ovary syndrome symptoms and metabolic syndrome. J Res Med Sci 22, 64, 2017.10.4103/jrms.JRMS_644_16546159428616051
]Search in Google Scholar
[
Lee MW, Park JK, Hong JW, et al. Beneficial effects of omega-3 fatty acids on low density lipoprotein particle size in patients with type 2 diabetes already under statin therapy. Diab Metab J 37, 207–211, 2013.10.4093/dmj.2013.37.3.207368901823807924
]Search in Google Scholar
[
Li L, Zhong Y, Zhang H, Yu H, Huang Y, Li Z, Chen G, Hua X. Association between oral contraceptive use as a risk factor and triple-negative breast cancer: A systematic review and meta-analysis. Mol Clin Oncol 7, 76–80, 2017.10.3892/mco.2017.1259549267128685080
]Search in Google Scholar
[
Mejia-Montilla J, Reyna-Villasmil E, Domínguez-Brito L, Naranjo-Rodríguez C, Noriega-Verdugoc D, Padilla-Samaniego M, Vargas-Olalla V. Suplementacion de acidos grasos omega-3 y adiponectina plasmatica en mu-jeres con sindrome de ovarios poliquisticos. Endocrinol Diabetes Nutr 65, 192–199, 2018.10.1016/j.endinu.2017.12.01029452758
]Search in Google Scholar
[
Mirmasoumi G, Fazilati M, Foroozanfard F, Vahedpoor Z, Mahmoodi S, Taghizadeh M, Esfeh NK, Mohseni M, Karbassizadeh H, Asemi Z. The Effects of flaxseed oil omega-3 fatty acids supplementation on metabolic status of patients with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial. Exp Clin Endocrinol Diab 126, 222–228, 2018.10.1055/a-1736-9017
]Search in Google Scholar
[
Mohammad-Alizadeh-Charandabi S, Mirghafourvand M, Froghy L, Javadzadeh Y, Razmaraii N. The effect of multivitamin supplements on continuation rate and side effects of combined oral contraceptives: A randomised controlled trial. Eur J Contracep Reprod Health Care 20, 361–371, 2015.10.3109/13625187.2015.101011525676163
]Search in Google Scholar
[
Mohammadi E, Rafraf M. Benefits of omega-3 fatty acids supplementation on serum paraoxonase 1 activity and lipids ratios in polycystic ovary syndrome. Health Promot Perspect 2, 197–204, 2012.
]Search in Google Scholar
[
Mohammadi E, Rafraf M, Farzadi L, Asghari-Jafarabadi M, Sabour S. Effects of omega-3 fatty acids supplementation on serum adiponectin levels and some metabolic risk factors in women with polycystic ovary syndrome. APJCN 21, 511–518, 2012.
]Search in Google Scholar
[
Moran LJ, Pasquali R, Teede HJ, Hoeger KM, Norman RJ. Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society. Fertil Steril 92, 1966–1982, 2009.10.1016/j.fertnstert.2008.09.01819062007
]Search in Google Scholar
[
Rafraf M, Mohammadi E, Asghari-Jafarabadi M, Farzadi L. Omega-3 fatty acids improve glucose metabolism without effects on obesity values and serum visfatin levels in women with polycystic ovary syndrome. JACN 31, 361–368, 2012.10.1080/07315724.2012.1072044323529993
]Search in Google Scholar
[
Nadjarzadeh A, Dehghani-Firouzabadi R, Daneshbodi H, Lotfi MH, Vaziri N, Mozaffari-Khosravi H. Effect of Omega-3 supplementation on Visfatin, adiponectin, and anthropometric indices in women with polycystic ovarian syndrome. J Reprod Infertil 16, 212–220, 2015.
]Search in Google Scholar
[
Najafi H, Changizi-ashtiyani S, Najafi M. Antioxidant activity of omega-3 derivatives and their elivery via nanocages and nanocones: DFT and experimental in vivo investigation. J Mol Model 23, 326, 2017.10.1007/s00894-017-3504-829080914
]Search in Google Scholar
[
Nybacka A, Carlstrom K, Stahle A, Nyren S, Hellstrom PM, Hirschberg AL. Randomized comparison of the influence of dietary management and/or physical exercise on ovarian function and metabolic parameters in over-weight women with polycystic ovary syndrome. Fertil Steril 96, 1508–1513, 2011.10.1016/j.fertnstert.2011.09.00621962963
]Search in Google Scholar
[
Oner G, Muderris II. Efficacy of omega-3 in the treatment of polycystic ovary syndrome. J Obstetr Gynecol 33, 289–291, 2013.10.3109/01443615.2012.75136523550861
]Search in Google Scholar
[
Phelan N, O’Connor A, Tun TK, Correia N, Boran G, Roche HM, Gibney J. Hormonal and metabolic effects of polyunsaturated fatty acids in young women with polycystic ovary syndrome: results from a cross-sectional analysis and a randomized, placebo-controlled, crossover trial. JACN 93, 652–662, 2011.10.3945/ajcn.110.00553821270384
]Search in Google Scholar
[
Palmery M, Saraceno A, Vaiarell A, Carlomagno G. Oral contraceptives and changes in nutritional requirements. Eur Rev Med Pharmacol Sci 17, 1804–1813, 2013.
]Search in Google Scholar
[
Rafraf M, Mohammadi E, Asghari-Jafarabadi M, Farzadi L. Omega-3 fatty acids improve glucose metabolism without effects on obesity values and serum visfatin levels in women with polycystic ovary syndrome. JACN 31, 361–368, 2012.10.1080/07315724.2012.1072044323529993
]Search in Google Scholar
[
Rahmani E, Samimi M, Ebrahimi FA, Foroozanfard F, Ahmadi S, Rahimi M, Jamilian M, Aghadavod E, Bahmani F, Taghizadeh M, Memarzadeh MR, Asemi Z. The effects of omega-3 fatty acids and vitamin E co-supplementation on gene expression of lipoprotein (a) and oxidized low-density lipoprotein, lipid profiles and biomarkers of oxidative stress in patients with polycystic ovary syndrome. Mol Cell Endocrinol 439, 247–255, 2016.10.1016/j.mce.2016.09.00827619403
]Search in Google Scholar
[
Rahmani E, Jamilian M, Dadpour B, Nezami Z, Vahedpoor Z, Mahmoodi S Aghadavod E, Taghizadeh M, Beiki Hassan A and Asemi Z. The effects of fish oil on gene expression in patients with polycystic ovary syndrome. EJCI 48, e12893, 2018.10.1111/eci.1289329359480
]Search in Google Scholar
[
Sadeghi A, Djafarian K, Mohammadi H, Shab-Bidar S. Effect of omega-3 fatty acids supplementation on insulin resistance in women with polycystic ovary syndrome: Meta-analysis of randomized controlled trials. Diabetes Metab Syndr: Clin Res Rev 11, 157–162, 2017.
]Search in Google Scholar
[
Sadeghi F, Alavi-Naeini A, Mardanian F, Ghazvini MR, Mahaki B. Omega-3 and vitamin E co-supplementation can improve antioxidant markers in obese/overweight women with polycystic ovary syndrome. Int J Vit Nutr Res 90, 477–483, 2020.10.1024/0300-9831/a00058830961460
]Search in Google Scholar
[
Silva RC, Pardini DP, Kater CE. Polycystic ovary syndrome, metabolic syndrome, cardiovascular risk and the role of insulin sensitizing agents. Braz Arq Endocrinol Metabol 50, 281–290, 2006.
]Search in Google Scholar
[
Silva DEA. Prevalence of metabolic disorders in polycystic ovarian syndrome. RBONE-Rev Bras Obes Nutr Emagr 7, 2, 2013. (Abstract)
]Search in Google Scholar
[
Stegeman BH, Bastos M, Rosendaal FR, Vlieg AVH, Helmerhorst FM, Stijnen T, Dekkers OM. Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis. BMJ 347, f5298, 2013.10.1136/bmj.f5298377167724030561
]Search in Google Scholar
[
Talari HR, Poladchang S, Hamidian Y, Samimi M, Gilasi HR, Ebrahimi FA, Asemi Z. The effects of omega-3 and vitamin E co-supplementation on carotid intima-media thickness and inflammatory factors in patients with polycystic ovary syndrome. OMJ 33, 473–479, 2018.10.5001/omj.2018.88620642830410689
]Search in Google Scholar
[
Thota RN, Ferguson JJA, Abbott KA, Dias CB, Garg ML. Science behind the cardio-metabolic benefits of omega-3 polyunsaturated fatty acids: Biochemical effects vs. clinical outcomes. Food Funct 9, 3576–3596, 2018.10.1039/C8FO00348C
]Search in Google Scholar
[
Unluhizarci K, Kaltsas G, Kelestimur F. Non polycystic ovary syndrome-related endocrine disorders associated with hirsutism. Eur J Clin Invest 42, 86–94, 2012.10.1111/j.1365-2362.2011.02550.x21623779
]Search in Google Scholar
[
Vargas ML, Almario RU, Buchan W, Kim K, Karakas SE. Metabolic and endocrine effects of long-chain versus essential omega-3 polyunsaturated fatty acids in polycystic ovary syndrome. Metabolism 60, 1711–1718, 2011.10.1016/j.metabol.2011.04.007321088421640360
]Search in Google Scholar
[
Yang K, Zeng L, Bao T, Ge J. Effectiveness of Omega-3 fatty acid for polycystic ovary syndrome: a systematic review and meta-analysis. Repr Biol Endocrinol 16, 27, 2018.10.1186/s12958-018-0346-x587091129580250
]Search in Google Scholar
[
Yao K, Bian C, Zhao X. Association of polycystic ovary syndrome with metabolic syndrome and gestational diabetes: Aggravated complication of pregnancy. Exp Ther Med 14, 1271–1276, 2017.10.3892/etm.2017.4642552611628810587
]Search in Google Scholar
